Utility and Safety of Perampanel in Pediatric FIRES and Other Drug-Resistant Epilepsies
Perampanel is a novel antiepileptic drug, which antagonises AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) glutamate receptor. We describe perampanel as an adjunctive treatment for FIRES (febrile infection-related epilepsy syndrome) and other drug-resistant epilepsies. A single-cent...
Saved in:
Main Authors: | Guo Yong Lim BSc(Pharm.)(Hons.), Chun Liang Chen PharmD, BCPPS, Derrick Chan Wei Shih MCI |
---|---|
Format: | article |
Language: | EN |
Published: |
SAGE Publishing
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/fbd11a58dee249bcbf5074a81317f09a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of COVID on pediatrics. “AEP’s pandemic term”
by: Maria José Mellado
Published: (2021) -
Pediatric eosinophilic esophagitis: a review for the clinician
by: Simona Barni, et al.
Published: (2021) -
Weight Change for Pediatric Completers in a National Weight Loss Program
by: Rochelle Cason-Wilkerson MD, MPH, et al.
Published: (2021) -
Simulation during COVID-19 pandemic in the Spanish pediatric intensive care units: New challenges in medical education
by: Laura Butragueño Laiseca, et al.
Published: (2021) -
Utility of the Infantile Hemangioma Referral Score (IHReS) as a decision-making tool for referral to treatment
by: Leelawadee Techasatian, et al.
Published: (2021)